| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, February 06, 2024 10:44:24 AM
I do not consider myself uninformed. I think this is the obvious circumstance. Flaskworks will come along shortly. I think I also previously predicted how they would get it approved, that it would not require human testing or any of the things some suggested and that you would be able to do multiple different batches at once in one system. All things that caused my assertions to be challenged.
It’s looking very good and very exciting, and the patent process as well, is extremely exciting. These will become core and very important patents for maintaining ownership of the Lysate + DCVaccine pipeline. Others will not only need to create, and trial and prove survival numbers comparable to DCVax-L, but they will also need the manufacturing technology. NWBO can become a go to for vaccine inventors and a partner for commercializing such vaccines also, if they want to go that route and if there are new innovations that make that a profitable and viable route. But most importantly, regardless, they will have a solid set of patent moats to protect the company and investors.
Very exciting PR in my opinion!
It’s looking very good and very exciting, and the patent process as well, is extremely exciting. These will become core and very important patents for maintaining ownership of the Lysate + DCVaccine pipeline. Others will not only need to create, and trial and prove survival numbers comparable to DCVax-L, but they will also need the manufacturing technology. NWBO can become a go to for vaccine inventors and a partner for commercializing such vaccines also, if they want to go that route and if there are new innovations that make that a profitable and viable route. But most importantly, regardless, they will have a solid set of patent moats to protect the company and investors.
Very exciting PR in my opinion!
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
